Cafepharma Today

May 13 2025 - GSK axes $625M TIGIT drug as midphase data disappoint, promoting partner iTeos to cut costs
GSK axes $625M TIGIT drug as midphase data disappoint, promoting partner iTeos to cut costs
Elizabeth Holmes’s partner reportedly raises millions for blood-testing startup
Bluebird bio warns of potential bankruptcy after another buyout delay
HIV market expected to reach $32.1bn by 2033 in 7MM
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

When Innovation Isn't Enough
InVivo
Monday, May 24, 2010 - 4:53pm
tags:
innovation
Genzyme, FDA settle on terms for troubled plant
Marketwatch
Monday, May 24, 2010 - 4:43pm
tags:
FDA, Genzyme, drug manufacturing
ASCO Abstracts -- Pops and Drops!
Motley Fool
Monday, May 24, 2010 - 4:30pm
tags:
ASCO, Keryx, Ziopharm, Celldex, Arqule, Delcath, Biogen Idec, Celgene, Bristol-Myers Squibb
Sequenom: Barclays Ups Target to $9; Confidence in Down Test Data
Barron's
Monday, May 24, 2010 - 4:26pm
tags:
Downs Syndrome, Sequenom
Athersys stem cell therapy wins scientists' plaudits
Mass Device
Monday, May 24, 2010 - 2:09pm
tags:
stem cells, Arthersys, MultiStem
BioLase to market P&G dental products
Bizjournals.com
Monday, May 24, 2010 - 2:06pm
tags:
BioLase, P&G, dental, licensing
Should Glaxo Test Paxil On Children?
Pharmalot
Monday, May 24, 2010 - 12:41pm
tags:
GSK, Paxil, antidepressants
Feds spell out the rules on $1B biotech windfall
Fierce Biotech
Monday, May 24, 2010 - 12:33pm
tags:
biotech, funding
Quintiles lays off staffers in shift to emerging markets
Fierce Biotech
Monday, May 24, 2010 - 12:27pm
tags:
Quintiles, emerging markets, layoffs
FDA panel review looms for controversial libido drug
Fierce Biotech
Monday, May 24, 2010 - 12:21pm
tags:
FDA, Boehringer Ingelheim, flibanserin
House committee sets J&J recall hearing
Fierce Pharma
Monday, May 24, 2010 - 12:07pm
tags:
JNJ, hearing, Tylenol, recalls
Acupuncture Treats Hot Flashes As Well As Effexor
Pharmalot
Monday, May 24, 2010 - 12:04pm
tags:
hot flashes, Pfizer, Effexor, acupuncture
Repligen drug gets FDA orphan drug status
Yahoo/AP
Monday, May 24, 2010 - 11:53am
tags:
Repligen, FDA, orphan drugs
Javelin dives on U.K. drug recall
Marketwatch
Monday, May 24, 2010 - 11:50am
tags:
Javelin, UK, recalls, Dyloject
Encouraging News for Bristol-Myers
Yahoo/Zacks.com
Monday, May 24, 2010 - 11:47am
tags:
Bristol-Myers Squibb, lung cancer, ipilimumab
Cell Therapeutics agrees to sell preferred stock
Yahoo/AP
Monday, May 24, 2010 - 8:04am
tags:
Cell Therapeutics, stock offering
Four Big Areas to Watch at the Upcoming ASCO Meeting, Biotech's Biggest Cancer Confab
BNET Pharma
Monday, May 24, 2010 - 8:03am
tags:
Avastin, Nektar, Sunesis, ASCO, cancer, vaccines, personalized medicine, ovarian cancer, Celgene, Revlimid, Rituxan, Roche, Dendreon, Provenge, Celldex, Pfizer, Argos, Plexxikon
King Pharmaceuticals: Financial Gauge Analysis for the March 2010 Quarter
Seeking Alpha
Monday, May 24, 2010 - 7:58am
tags:
earnings, King, financial
Zacks Analyst Blog Highlights: Amgen Inc., Novartis, Merck, GlaxoSmithKline and Eli Lilly
Yahoo/Zacks.com
Monday, May 24, 2010 - 7:56am
tags:
Amgen, Merck, Eli Lilly, GSK, Novartis
Clinical Data gets approval of depression drug
Yahoo/AP
Monday, May 24, 2010 - 7:54am
tags:
Clinical Data, FDA, antidepressants, Vilazodone, Merck Serono

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.